Loading company
Charles River Laboratories International, Inc.
CRL · NYSE · Healthcare · Diagnostics and Research
Next earnings: November 4, 2026
$296.11+0.5%Sep 29 close
- 1M
- +1.6%
- 6M
- +85.4%
- 1Y
- +89.3%
- 5Y
- -31.5%
CRL · NYSE · Healthcare · Diagnostics and Research
Next earnings: November 4, 2026
$296.11+0.5%Sep 29 close
Charles River Laboratories International, Inc. is scheduled to report next on November 4, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 27, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 27, 2026 | 3 months toJun 28, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1B | $1B | -2.72% |
| Profit | -$1.5M | $52.3M | -102.83% |
| Profit per share | -$0.03 | $1.06 | -102.83% |
| Free Cash Flow | $148.6M | $169.3M | -12.22% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com. # # # Investor
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Charles River Laboratories International, Inc.’s Item 2.02 8-K filed August 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Charles River Laboratories International, Inc. has no earnings call transcript available.